The stock makes the Nasdaq top gainer list on a massive $1.085 Billion pharma deal. The stock is trading at $1.6300, up ...

Chugai Pharma & Rani Therapeutics ink agreement to develop and commercialize oral formulation leveraging RaniPill technology: Tokyo Wednesday, October 22, 2025, 12:00 Hrs [IST] Ch ...

Q3 2025 Earnings Call Transcript October 21, 2025 Northrop Grumman Corporation beats earnings expectations. Reported EPS is ...

Rani will receive $10 million upfront payment and is eligible to receive up to $75 million in technology transfer and development milestones, up ...

For 3 months ended September 30, Third Avenue Value Fund returned 11.85%, as compared to the MSCI World Index, which returned ...

Discover why Federal Realty Investment Trust is a Buy with a 4.6% yield, robust growth, and discounted shares. Click for my ...

Q3 2025 Earnings Call Transcript October 21, 2025 Philip Morris International Inc. beats earnings expectations. Reported EPS ...

Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third-quarter 2025 investor letter. A ...

Application error: a client-side exception has occurred (see the browser console for more information).

DNTH212 is a bifunctional fusion protein targeting plasmacytoid dendritic cell (pDC) BDCA2 to reduce Type 1 interferon production, while ...